Indefinite Delivery Contract 75D30125D20639
- Not listed
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a Blanket Purchase Agreement (BPA) to Mriglobal, also doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The BPA, valued at up to $7,847,794, covers the provision of bacterial panels and challenger panels to support the CDC's infectious disease monitoring and prevention programs. Under the BPA, the CDC has issued two task orders to Mriglobal...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) has awarded a single-award, $100 million Indefinite Delivery Contract (IDC) to Mriglobal (dba Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The contract, which has a period of performance through September 2027, is for the development of biological animal models and medical countermeasures. Under this IDC, ASPR can issue task orders for a variety...
- This federal Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Mriglobal (doing business as Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The $40 million IDC, titled "Pre-Clinical Models of Infectious Diseases", has an ultimate completion date of July 13, 2024 and is part of the larger NIAID Preclinical Models of...
- This federal contract award is an Indefinite Delivery, Indefinite Quantity (IDIQ) contract for the Diagnostics Pre-Clinical Services Program, awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to the prime contractor MRI Global, also doing business as Midwest Research Institute. The contract has a potential value of $24,000,000 and a period of performance through June 2030. Under this IDIQ, MRI Global...
- This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The $257,774.96 contract, awarded on May 4, 2006, is for the development of a "Simplified Rapid Biological Detector for Food." Mriglobal is an experienced federal contractor, holding several significant IDVs with agencies such as the...
- This federal Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The $49,990,000 single-award IDC has an ultimate completion date of June 30, 2028 and does not have a set-aside designation. Under this IDC, Mriglobal is providing a range of scientific research, testing, and product...
- This indefinite delivery contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a component of the U.S. Department of Health and Human Services (HHS), to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The $45 million single-award IDC has a period of performance through July 31, 2025 and is for the development of animal models to evaluate the efficacy of medical countermeasures (MCMs)...
- The federal contract IDV award GS10F0127J is a Federal Supply Schedule (FSS) contract, a multiple award vehicle that allows for rapid procurement of diverse services from the prime contractor, Mriglobal (doing business as Midwest Research Institute). Mriglobal is a 501(c)(3) not-for-profit research organization that supports federal agencies such as the Department of Health and Human Services, Department of Defense, and Department of Homeland Security with a range of scientific research,...
- The provided information describes a $148,000,000 Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The IDC is designated as a "DIAGNOSTIC TESTING IDIQ" and has an ultimate completion date of September 29, 2030. Cepheid, as the prime contractor, will provide the CDC with a range of molecular diagnostic systems, test kits, and associated maintenance services...
- The Department of Homeland Security (DHS) awarded a $2 billion Indefinite Delivery, Indefinite Quantity (IDIQ) contract to MRIGlobal, doing business as Midwest Research Institute, to provide COVID-19 testing solutions. The IDIQ contract has a one-year base period and four one-year option periods, and it allows DHS to rapidly procure test kits for molecular diagnostic, antigen, and antibody testing, as well as managed testing services. The contracted solutions must meet requirements for sample...
Mriglobal (doing business as Midwest Research Institute), a 501(c)(3) not-for-profit research organization headquartered in Kansas City, Missouri, was awarded a multiple-award Indefinite Delivery Contract valued at $148 million by the Centers for Disease Control and Prevention (CDC) Pittsburgh for diagnostic testing services. The contract was awarded on September 29, 2025, with an ultimate completion date of September 29, 2030, and utilizes no set-aside provisions, reflecting Mriglobal's status as a large, experienced prime contractor. This Diagnostic Testing Indefinite Delivery Indefinite Quantity (IDIQ) contract provides the CDC with flexible procurement authority to issue task orders for specialized diagnostic testing capabilities and related scientific services essential to the agency's public health missions. Under this IDV, Mriglobal will leverage its sophisticated laboratory facilities and technical expertise to support the CDC's diagnostic testing requirements, which may encompass infectious disease testing, biosafety evaluation, analytical testing, and other diagnostic services aligned with the agency's disease surveillance and response capabilities. Based on Mriglobal's extensive portfolio of federal contracts with the Centers for Disease Control and Prevention and other public health agencies, the organization is well-positioned to provide clinical-grade diagnostic services, method development, and testing infrastructure to support the CDC's ongoing public health initiatives. The five-year contract period provides the CDC with access to Mriglobal's advanced scientific resources on an as-needed basis, enabling rapid deployment of diagnostic testing capacity in support of national public health priorities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 9/19/25 |